One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editor’s Choice – John Ingram – February 2023
doi : 10.1093/bjd/ljac148
British Journal of Dermatology, Volume 188, Issue 2, February 2023, Pages i–ii
World Health Organization strategic framework for integrated control and management of skin-related neglected tropical diseases: what does this mean for dermatologists?
Rie R Yotsu, L Claire Fuller, Michele E Murdoch, Chandrakant Revankar, Yves Thierry Barogui, Venkata Ranganandha Rao Pemmaraju, Jose-Antonio Ruiz-Postigo, Daniel Argaw Dagne, Kingsley Asiedu, Roderick J Hay
doi : 10.1093/bjd/ljac031
Current understanding of the phenotypic spectrum of patients with NLRP1 variants
Takuya Takeichi, Masashi Akiyama
doi : 10.1093/bjd/ljac036
Occupational exposure to cobalt nanoparticles: potential implications on risk assessment and preventive measures
Cara Symanzik, Swen Malte John
doi : 10.1093/bjd/ljac053
Psoriasis treatment does not impair the immunogenicity of ChAOx1-S[recombinant] COVID-19 vaccination
LluÃs Puig
doi : 10.1093/bjd/ljac081
Dose flexibility of oral Janus kinase inhibitors for long-term control of atopic dermatitis
Toshiya Ebata
doi : 10.1093/bjd/ljac082
Update on the management of Bowen disease with a focus on patients’ needs
Carola Berking
doi : 10.1093/bjd/ljac087
Apples and oranges? Making sense of global keratinocyte cancer data
Zoe C Venables
doi : 10.1093/bjd/ljac102
Photoprotection for people with skin of colour: needs and strategies
Jean Krutmann, Jaime Piquero-Casals, Daniel Morgado-Carrasco, Corinne Granger, Carles Trullà s, Thierry Passeron, Henry W Lim
doi : 10.1093/bjd/ljac046
Anatomical contacts between sensory neurons and epidermal cells: an unrecognized anatomical network for neuro-immuno-cutaneous crosstalk
Matthieu Talagas
doi : 10.1093/bjd/ljac066
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma in situ (Bowen disease) 2022
Ashish Sharma, Andrew J Birnie, Cristina Bordea, Seau Tak Cheung, Jasmine Mann, Colin A Morton, Asad Salim, Zeeshaan-Ul Hasan, Maria Hashme, Zahra Mansour Kiaee, M Firouz Mohd Mustapa, Lesley S Exton
doi : 10.1093/bjd/ljac042
Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
Sheila M McSweeney, Tuntas Rayinda, John A McGrath, Christos Tziotzios
doi : 10.1093/bjd/ljac050
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials
Richard G Langley, Howard Sofen, Ignacio Dei-Cas, Kristian Reich, Bardur Sigurgeirsson, Richard B Warren, Carle Paul, Jacek C Szepietowski, Tsen-Fang Tsai, Isabelle Hampele, Ruquan You, Pascal Charef, Charis Papavassilis
doi : 10.1093/bjd/ljac040
Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3
Kristian Reich, Eric Simpson, Andreas Wollenberg, Robert Bissonnette, Masatoshi Abe, Tracy Cardillo, Jonathan Janes, Luna Sun, Sherry Chen, Jonathan I Silverberg
doi : 10.1093/bjd/ljac057
Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
Brett King, Arash Mostaghimi, Yutaka Shimomura, Abraham Zlotogorski, Gwang-Seong Choi, Ulrike Blume-Peytavi, Thierry Passeron, Katrin Holzwarth, Yves Dutronc, Jill McCollam, Fan Emily Yang, Sarah Stanley, Wen-Shuo Wu, Rodney Sinclair
doi : 10.1093/bjd/ljac059
Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004–2018: a cohort study
Khaylen Mistry, Nick J Levell, Loes Hollestein, Marlies Wakkee, Tamar Nijsten, Craig S Knott, Neil M Steven, Paul J Craig, Zoe C Venables
doi : 10.1093/bjd/ljac044
Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017
Dorothy D Yang, Kim Borsky, Chinmay Jani, Conor Crowley, Jeremy N Rodrigues, Rubeta N Matin, Dominic C Marshall, Justin D Salciccioli, Joseph Shalhoub, Richard Goodall
doi : 10.1093/bjd/ljac064
Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials
Viktoria Eleftheriadou, Christina Bergqvist, Elio Kechichian, Jason Shourick, Hyun-Jeong Ju, Nanja van Geel, Jung Min Bae, Khaled Ezzedine
doi : 10.1093/bjd/ljac074
A homozygous p.Leu813Pro gain-of-function NLRP1 variant causes phenotypes of different severity in two siblings
Mingfeng Li, Kenneth Lay, Andreas Zimmer, Kristin Technau-Hafsi, Jasmine Wong, Antonia Reimer-Taschenbrecker, Jan Rohr, Ebtesam Abdalla, Judith Fischer, Bruno Reversade, Cristina Has
doi : 10.1093/bjd/ljac039
A real-world prospective cohort study of immunogenicity and reactogenicity of ChAdOx1-S[recombinant] among patients with immune-mediated dermatological diseases
Kumutnart Chanprapaph, Chutima Seree-aphinan, Ploysyne Rattanakaemakorn, Cherrin Pomsoong, Yanisa Ratanapokasatit, Chavachol Setthaudom, Arunee Thitithanyanont, Aphinyaphiwat Suriyo, Thanitta Suangtamai, P Suchonwanit, the COVIDVAC-DERM study group
doi : 10.1093/bjd/ljac045
Cobalt nanoparticles cause allergic contact dermatitis in humans
Klara Midander, Paulina Werner, Marléne Isaksson, Lukas Wisgrill, Carola Lidén, Nanna Fyhrquist, Anneli Julander
doi : 10.1093/bjd/ljac043
Topical corticosteroid withdrawal syndrome: the patient community call for high-quality research, clear definitions and diagnostic criteria
Laura Howells, Holly Broome, Alice Burleigh, Harriet Hammond, Farhan Ismail, Andrew Proctor, Amanda Roberts, Kim S. Thomas, Paul Leighton
doi : 10.1093/bjd/ljac067
B-cell-derived transforming growth factor-β may drive the activation of inflammatory macrophages and contribute to scarring in hidradenitis suppurativa
Conor M Smith, Roisin Hambly, Solene Gatault, Luis F Iglesias-Martinez, Sean Kearns, Helen Rea, Vivien Marasigan, Kate Lynam-Loane, Shivashini Kirthi, Rosalind Hughes, Jean M Fletcher, Walter Kolch, Brian Kirby
doi : 10.1093/bjd/ljac048
Evaluation of diagnosis diversity in artificial intelligence datasets: a scoping review
Michael L Chen, Veronica Rotemberg, Jenna C Lester, Roberto A Novoa, Albert S Chiou, Roxana Daneshjou
doi : 10.1093/bjd/ljac047
Strongyloides screening prior to dupilumab therapy in atopic dermatitis: a retrospective cohort study evaluating screening utility
Kyra Gill, Jennifer Xu, Emily Kozera, Thomas Stewart, Akshay Flora, John W Frew
doi : 10.1093/bjd/ljac060
Safety outcomes for topical corticosteroid use in eczema herpeticum: a single-centre retrospective cohort study
Lloyd Steele, Stuart Innes, Jaimie Oldham, Malvina Cunningham, Sasha Dhoat, Bryan McDonald, Edel A O’Toole
doi : 10.1093/bjd/ljac051
Is vaccination against COVID-19 associated with psoriasis or eczema flare? Self-controlled case series analysis using data from the Clinical Practice Research Datalink (Aurum)
Laura Adams, Georgina Nakafero, Matthew J Grainge, Tim Card, Christian D Mallen, Jonathan S Nguyen Van-Tam, Hywel C Williams, Abhishek Abhishek
doi : 10.1093/bjd/ljac061
Factors contributing to time to chemotherapy, immunotherapy and radiation for patients with mycosis fungoides in the United States National Cancer Database
Jessica B. Brown-Korsah, Deega Omar, Xingmei Wang, Susan C. Taylor, Alain H. Rook, Paul L. Haun
doi : 10.1093/bjd/ljac069
Psoriasis and fatigue: a cross-sectional population study of psoriasis patients in the United States using the Medical Expenditure Panel Surveys
Caterina Zagona-Prizio, Sabrina Khan, Danielle K Yee, Samiya Khan, Nicole Maynard, Rasika Reddy, Manan D Mehta, April W Armstrong
doi : 10.1093/bjd/ljac071
A skin disease survey of the Maasai in North Eastern Tanzania
Sidra S Khan, Darren M Ashcroft, Ncoza Dlova, Luly C Kini, Daudi Mavura, Rune N Philemon, Doriane Sabushmike, Rebekah Swan, Nirohshah Trialonis-Suthakharan, Tina Tian, Aakash Varma, Christopher E M Griffiths
doi : 10.1093/bjd/ljac065
Prevalence of rosacea in transgender and gender-diverse populations: a retrospective cohort study
Jessika Sanz, Julia L Gao, Dana S King, Anna M Modest, Erica D Dommasch
doi : 10.1093/bjd/ljac041
Treatment of multifactorial anaemia in adults with severe epidermolysis bullosa using intravenous ferric carboxymaltose: a single institution, observational, retrospective study
Ashjan Alheggi, John A McGrath, Lynne Hubbard, Danielle T Greenblatt, Jemima E Mellerio
doi : 10.1093/bjd/ljac075
The efficacy of learning programmes on hairstylists and barbers in the early detection of alopecia and scalp disorders in South Africa
Kiasha Govender, Wilbert Sibanda, Yolanda Lenzy, Ncoza Cordelia Dlova Author Notes
doi : 10.1093/bjd/ljac077
Inflammatory induration in hidradenitis suppurativa and application to severity assessment
Gretchen Bellefeuille, Briana Paiewonsky, Bisma Khalid, Rebecca L Freese, Michelle A Lowes, Joslyn S Kirby, Afsaneh Alavi, Noah Goldfarb
doi : 10.1093/bjd/ljac076
A review of the role of four types of epidermal cells in messaging between the skin, nervous system and immune system
doi : 10.1093/bjd/ljac158
Guidelines from the British Association of Dermatologists for the management of people with squamous cell carcinoma in situ (Bowen disease)
doi : 10.1093/bjd/ljac160
Patients successfully treated with baricitinib for atopic dermatitis: what happens if they lower their dose or stop treatment?
doi : 10.1093/bjd/ljac159
Merkel cell carcinoma: changes in the number of people affected, treatment and survival between 2004 and 2018
doi : 10.1093/bjd/ljac157
A review of the outcome measures used in clinical trials for vitiligo
British Journal of Dermatology, Volume 188, Issue 2, February 2023, Page e17
doi : 10.1093/bjd/ljac163
Greater understanding about a rare inherited skin disorder from a study of NLRP1 in two sisters with different severity of disease
doi : 10.1093/bjd/ljac151
Responses to AstraZeneca COVID-19 vaccines in patients with immune-mediated skin diseases
doi : 10.1093/bjd/ljac161
